News
Of these, 627 patients who showed a suboptimal response after 8 weeks of treatment with olmesartan medoxomil 20 mg/day were randomised to receive olmesartan medoxomil 40 mg/day (n = 302 ...
Following placebo run-in, all patients received olmesartan medoxomil 20 mg/d for 4 weeks. At subsequent 4-week intervals, the regimen was modified in patients with blood pressure >130/85 mm Hg ...
Lorundrostat effectively reduced 24-hour blood pressure in patients with well-treated, uncontrolled hypertension in the phase ...
10d
MedPage Today on MSNLorundrostat Lowered BP in Uncontrolled, Treatment-Resistant HypertensionParticipants with uncontrolled and otherwise treatment-resistant hypertension showed significant blood pressure improvement ...
The MG4 is one of the most popular electric vehicles in the UK. The Chinese-made car is stylish, well-appointed, and keenly priced, making it a danger to Tesla. The XPower version I tested is ...
The European Medicines Agency’s detection of a second nitrosamine in a sartan API is driving a deeper dive into tetrazole chemistry; root-cause investigations will now include not only valsartan and ...
When taken by mouth: Lutein is likely safe when taken by mouth. Consuming up to 20 mg of lutein daily as part of the diet or as a supplement appears to be safe.
In the lowest dose, the whole bottle contains a total of 1,500 mg of CBD. There are 60 gummies in the bottle, meaning each gummy has 25 mg of CBD, a first-time-friendly serving size. It’s a suit ...
BT11 exhibited significantly faster drug release compared to the commercially available product benidipine T (4 mg/40 mg) and the pure drugs BD and TEL, releasing more than 96% of both drugs in 0.1 N ...
Vivacity-MG3 is a Phase III, randomised, double-blind, placebo-controlled study conducted at 81 outpatient centres with expertise in MG in 17 countries in Asia–Pacific, Europe, and North America.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results